Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
15-04-20	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
15-01-30	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
14-12-05	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
14-11-20	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
14-11-18	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
14-10-28	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
14-07-31	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
14-07-25	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
14-07-17	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
14-06-24	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
14-06-19	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

15-03-04	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
15-01-28	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
14-12-06	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
14-12-01	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
14-07-29	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

14-07-17	Novartis : confirme l'objectif de croissance de ses ventes
14-07-17	Novartis : confirme l'objectif de croissance du C.A. annuel
14-06-19	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
14-04-22	S& 500 : Vague de fusions dans le domaine de la pharmacie
14-04-07	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.56%	-1.52%	+47.86%	+171.88%	1,060B
JOHNSON & JOHNSON	+0.31%	-0.60%	+64.37%	+62.31%	619B
ABBVIE INC.	-0.03%	-2.65%	+29.49%	+85.64%	438B
ROCHE HOLDING AG	-1.75%	-2.91%	+28.78%	+24.35%	333B
NOVARTIS AG	+0.24%	-2.61%	+29.46%	+46.50%	282B
ASTRAZENECA PLC	-1.75%	-12.77%	+20.67%	+23.05%	267B
NOVO NORDISK A/S	+0.67%	-0.76%	-26.10%	-37.25%	218B
AMGEN INC.	-0.81%	-1.63%	+21.35%	+58.33%	196B
GILEAD SCIENCES, INC.	+1.21%	+1.38%	+17.23%	+71.29%	161B
Average	-0.38%	-3.33%	+25.90%	+56.23%	397.1B
Weighted average by Cap.	-0.27%	-3.10%	+35.85%	+84.06%

Employees

Sector